TOB1 and respiratory tract infectious disorder: While both AZM and TOB target bacterial protein synthesis, their mechanisms and clinical applications differ; TOB binds to the 30S ribosomal subunit, causing misreading of mRNA and bactericidal effects, and AZM, although targeting the 50S ribosomal subunit [45], is not primarily used as a bactericidal agent in respiratory infections.